Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B

Abstract This study evaluated the long-term efficacy and safety of the widely used drugs entecavir (ETV) and tenofovir alafenamide (TAF), as well as the incidence of HCC.A nonrandomized, prospective, observational analysis included 77 patients with chronic hepatitis B who were assigned to continue E...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Takuya Matsubara, Satoru Hagiwara, Naoshi Nishida, Naoya Omaru, Akihiro Yoshida, Tomoki Yamamoto, Yoriaki Komeda, Mamoru Takenaka, Masatoshi Kudo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2025-01-01
coleção:	Scientific Reports
Assuntos:	Carcinogenesis Efficacy Entecavir Hepatitis B virus Safety Tenofovir alafenamide
Acesso em linha:	https://doi.org/10.1038/s41598-025-85317-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!